Earl Albone

Earl Albone

Company: Eisai

Job title: Senior Director, Biochemistry Discovery


Exploring MORAb-109: A Site-Specific Eribulinconjugated ADC Targeting Human Mesothelin 3:00 pm

• MORAb-109 is a humanized DAR2 eribulin-conjugated ADC targeting human mesothelin that utilizes Eisai’s proprietary RESPECT-L technology • Evaluate how, in preclinical in vivo studies, MORAb-109 demonstrated dose-dependent anti-tumor activity, with regression observed in multiple patient-derived xenograft models including models with heterogeneous mesothelin expression • Discover how MORAb-109 exhibited stability in vivo in rodent and…Read more

day: day 1 track 2 pm

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.